Pain resolution and glucose control in pediatric patients with chronic pancreatitis after total pancreatectomy with islet auto-transplantation.
Glucose control
Opioids
Pain
Quality of life
TPIAT
Journal
Pediatric surgery international
ISSN: 1437-9813
Titre abrégé: Pediatr Surg Int
Pays: Germany
ID NLM: 8609169
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
accepted:
26
06
2021
pubmed:
11
7
2021
medline:
16
10
2021
entrez:
10
7
2021
Statut:
ppublish
Résumé
Chronic pancreatitis (CP) and acute recurrent pancreatitis (ARP) in pediatric patients are strongly associated with genetic mutations and lead to pan-parenchymal disease refractory to medical and endoscopic treatment. Our aim was to assess pain resolution and glucose control in patients with CP and ARP following total pancreatectomy with islet auto-transplantation (TPIAT). We retrospectively analyzed prospectively collected clinical data of 12 children who developed CP and ARP and underwent TPIAT when 21 years old or younger at the University of Chicago between December 2009 and June 2020. Patients with recurrent or persistent abdominal pain attributed to acute or chronic pancreatic inflammation and a history of medical interventions attempted for the relief of pancreatic pain were selected by a multi-disciplinary team for TPIAT. We followed patients post-operatively and reported data for pre-TPIAT, post-operative day 75, and yearly post-TPIAT. All 12 patients experienced complete resolution of pancreatic pain. The overall insulin-independence rate after 1 year was 66% (8/12) and 50% (3/6) at 4 years. Shorter duration of CP/ARP pre-TPIAT, higher mass of islets infused, and lower BMI, BMI percentile, and BSA were associated with insulin-independence post-TPIAT. TPIAT is a viable treatment option for pediatric patients with CP and ARP. Pediatric patients undergoing TPIAT for CP achieved resolution of pancreatic-type pain and reduced opioid requirements. The majority were able to achieve insulin-independence which was associated with lower pre-TPIAT BMI and higher islet mass transplanted (i.e., over 2000 IEQ/kg), the latter of which can be achieved by earlier TPIAT. Treatment study, Level IV.
Sections du résumé
BACKGROUND
BACKGROUND
Chronic pancreatitis (CP) and acute recurrent pancreatitis (ARP) in pediatric patients are strongly associated with genetic mutations and lead to pan-parenchymal disease refractory to medical and endoscopic treatment. Our aim was to assess pain resolution and glucose control in patients with CP and ARP following total pancreatectomy with islet auto-transplantation (TPIAT).
METHODS
METHODS
We retrospectively analyzed prospectively collected clinical data of 12 children who developed CP and ARP and underwent TPIAT when 21 years old or younger at the University of Chicago between December 2009 and June 2020. Patients with recurrent or persistent abdominal pain attributed to acute or chronic pancreatic inflammation and a history of medical interventions attempted for the relief of pancreatic pain were selected by a multi-disciplinary team for TPIAT. We followed patients post-operatively and reported data for pre-TPIAT, post-operative day 75, and yearly post-TPIAT.
RESULTS
RESULTS
All 12 patients experienced complete resolution of pancreatic pain. The overall insulin-independence rate after 1 year was 66% (8/12) and 50% (3/6) at 4 years. Shorter duration of CP/ARP pre-TPIAT, higher mass of islets infused, and lower BMI, BMI percentile, and BSA were associated with insulin-independence post-TPIAT.
CONCLUSIONS
CONCLUSIONS
TPIAT is a viable treatment option for pediatric patients with CP and ARP. Pediatric patients undergoing TPIAT for CP achieved resolution of pancreatic-type pain and reduced opioid requirements. The majority were able to achieve insulin-independence which was associated with lower pre-TPIAT BMI and higher islet mass transplanted (i.e., over 2000 IEQ/kg), the latter of which can be achieved by earlier TPIAT.
LEVEL OF EVIDENCE
METHODS
Treatment study, Level IV.
Identifiants
pubmed: 34245339
doi: 10.1007/s00383-021-04956-5
pii: 10.1007/s00383-021-04956-5
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1383-1392Subventions
Organisme : NIDDK NIH HHS
ID : P30DK020595
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30DK020595
Pays : United States
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Schwarzenberg SJ, Bellin M, Husain SZ, Ahuja M, Barth B, Davis H et al (2015) Pediatric chronic pancreatitis is associated with genetic risk factors and substantial disease burden. J Pediatr 166:890-896.e1. https://doi.org/10.1016/j.jpeds.2014.11.019
doi: 10.1016/j.jpeds.2014.11.019
pubmed: 25556020
Németh BC, Sahin-Tóth M (2014) Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis. Am J Physiol Liver Physiol 306:G466–G473. https://doi.org/10.1152/ajpgi.00419.2013
doi: 10.1152/ajpgi.00419.2013
Pohl JF, Limbers CA, Kay M, Harman A, Rollins M, Varni JW (2012) Health-related quality of life in pediatric patients with long-standing pancreatitis. J Pediatr Gastroenterol Nutr 54:657–663. https://doi.org/10.1097/MPG.0b013e3182407c4f
doi: 10.1097/MPG.0b013e3182407c4f
pubmed: 22094900
Abu-El-Haija M, Nathan JD (2018) Pediatric chronic pancreatitis: updates in the 21st century. Pancreatology 18:354–359. https://doi.org/10.1016/j.pan.2018.04.013
doi: 10.1016/j.pan.2018.04.013
pubmed: 29724605
Gołębiewska JE, Bachul PJ, Fillman N, Kijek MR, Basto L, Para M et al (2019) Early infectious complications after total pancreatectomy with islet autotransplantation: a single center experience. J Gastrointest Surg 23:2201–2210. https://doi.org/10.1007/s11605-019-04118-y
doi: 10.1007/s11605-019-04118-y
pubmed: 30719679
Witkowski P, Savari O, Matthews JB (2014) Islet autotransplantation and total pancreatectomy. Adv Surg 48:223–233. https://doi.org/10.1016/j.yasu.2014.05.006
doi: 10.1016/j.yasu.2014.05.006
pubmed: 25293618
pmcid: 4435940
Savari O, Golab K, Wang L-J, Schenck L, Grose R, Tibudan M et al (2015) Preservation of beta cell function after pancreatic islet autotransplantation: university of chicago experience. Am Surg 81:421–427. https://doi.org/10.1177/000313481508100435
doi: 10.1177/000313481508100435
pubmed: 25831191
Washington State Agency Medical Directors Group (2010) Interagency guideline on opioid dosing for chronic non-cancer pain: an educational aid to improve care and safety with opioid therapy. Washington State Agency Med Dir Site www.AgencymeddirectorsWaGov
Gołębiewska JE, Bachul PJ, Fillman N, Basto L, Kijek MR, Gołąb K et al (2019) Assessment of simple indices based on a single fasting blood sample as a tool to estimate beta-cell function after total pancreatectomy with islet autotransplantation a prospective study. Transpl Int 32:280–290. https://doi.org/10.1111/tri.13364
doi: 10.1111/tri.13364
pubmed: 30353611
Bachul PJ, Golab K, Basto L, Borek P, Perea L, Tibudan M et al (2021) Long-term stability of β-cell graft function after total pancreatectomy and islet autotransplantation. Pancreas 50:e2-4. https://doi.org/10.1097/MPA.0000000000001711
doi: 10.1097/MPA.0000000000001711
pubmed: 33370034
pmcid: 7806119
Chinnakotla S, Bellin MD, Schwarzenberg SJ, Radosevich DM, Cook M, Dunn TB et al (2014) Total pancreatectomy and islet autotransplantation in children for chronic pancreatitis. Ann Surg 260:56–64. https://doi.org/10.1097/SLA.0000000000000569
doi: 10.1097/SLA.0000000000000569
pubmed: 24509206
Witkowski P, Philipson L, Kaufman DB, Ratner L, Abouljoud MS, Bellin M, et al (2020) The demise of islet allotransplantation in the us: a call for an urgent regulatory update the “ISLETS FOR US” collaborative. Am J Transplant ajt.16397. https://doi.org/10.1111/ajt.16397
Wilhelm JJ, Bellin MD, Dunn TB, Balamurugan AN, Pruett TL, Radosevich DM et al (2013) Proposed thresholds for pancreatic tissue volume for safe intraportal islet autotransplantation after total pancreatectomy. Am J Transplant 13:3183–3191. https://doi.org/10.1111/ajt.12482
doi: 10.1111/ajt.12482
pubmed: 24148548
pmcid: 4087156
Kotagal M, Slusher J, Ahmad S, Aronson LA, Brunner J, Chima R et al (2019) In-hospital and 90-day outcomes after total pancreatectomy with islet autotransplantation for pediatric chronic and acute recurrent pancreatitis. Am J Transplant 19:1187–1194. https://doi.org/10.1111/ajt.15150
doi: 10.1111/ajt.15150
pubmed: 30372594
Bellin MD, Beilman GJ, Sutherland DE, Ali H, Petersen A, Mongin S et al (2019) How durable is total pancreatectomy and intraportal islet cell transplantation for treatment of chronic pancreatitis? J Am Coll Surg 228:329–339. https://doi.org/10.1016/j.jamcollsurg.2018.12.019
doi: 10.1016/j.jamcollsurg.2018.12.019
pubmed: 30630085
Bachul PJ, Grybowski DJ, Anteby R, Basto L, Perea L, Golab K et al (2020) Total pancreatectomy with islet autotransplantation in diabetic and pre-diabetic patients with intractable chronic pancreatitis. J Pancreatol 3:86–92. https://doi.org/10.1097/JP9.0000000000000048
doi: 10.1097/JP9.0000000000000048
pubmed: 33005475
pmcid: 7526866
Bellin MD, Forlenza GP, Majumder K, Berger M, Freeman ML, Beilman GJ et al (2017) Total pancreatectomy with islet autotransplantation resolves pain in young children with severe chronic pancreatitis. J Pediatr Gastroenterol Nutr 64:440–445. https://doi.org/10.1097/MPG.0000000000001314
doi: 10.1097/MPG.0000000000001314
pubmed: 28231072
pmcid: 5327823
Bellin MD, Gelrud A, Arreaza-Rubin G, Dunn TB, Humar A, Morgan KA et al (2015) Total pancreatectomy with islet autotransplantation. Ann Surg 261:21–29. https://doi.org/10.1097/SLA.0000000000001059
doi: 10.1097/SLA.0000000000001059
pubmed: 25599324
Solomina J, Gołębiewska J, Kijek MR, Kotukhov A, Bachul PJ, Basto L et al (2017) Pain control, glucose control, and quality of life in patients with chronic pancreatitis after total pancreatectomy with islet autotransplantation: a preliminary report. Transplant Proc 49:2333–2339. https://doi.org/10.1016/j.transproceed.2017.10.010
doi: 10.1016/j.transproceed.2017.10.010
pubmed: 29198673
Cortez AR, Kassam A-F, Lin TK, Paulsen GC, Brunner J, Jenkins TM et al (2020) Sterility cultures following pancreatectomy with islet autotransplantation in the pediatric population: do they matter? J Gastrointest Surg 24:2526–2535. https://doi.org/10.1007/s11605-019-04413-8
doi: 10.1007/s11605-019-04413-8
pubmed: 31745897
Ali HM, Bellin MD, Boucher AA, Northup EF, Florek ER, Wilhelm JJ et al (2020) Safety and clinical outcomes of using low–molecular-weight dextran during islet autotransplantation in children. Pancreas 49:774–780. https://doi.org/10.1097/MPA.0000000000001571
doi: 10.1097/MPA.0000000000001571
pubmed: 32541632
Chinnakotla S, Beilman GJ, Dunn TB, Bellin MD, Freeman ML, Radosevich DM et al (2015) Factors predicting outcomes after a total pancreatectomy and islet autotransplantation lessons learned from over 500 cases. Ann Surg 262:610–622. https://doi.org/10.1097/SLA.0000000000001453
doi: 10.1097/SLA.0000000000001453
pubmed: 26366540
Balamurugan AN, Elder DA, Abu-El-Haija M, Nathan JD (2020) Islet cell transplantation in children. Semin Pediatr Surg 29:150925. https://doi.org/10.1016/j.sempedsurg.2020.150925
doi: 10.1016/j.sempedsurg.2020.150925
pubmed: 32571510
Bellin MD, Abu-El-Haija M, Morgan K, Adams D, Beilman GJ, Chinnakotla S et al (2018) A multicenter study of total pancreatectomy with islet autotransplantation (TPIAT): POST (Prospective Observational Study of TPIAT). Pancreatology 18:286–290. https://doi.org/10.1016/j.pan.2018.02.001
doi: 10.1016/j.pan.2018.02.001
pubmed: 29456124